Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + • Oliguric (urinary output < 400 mL/d) and nonoliguric• Mortality in surgical ICU of 50-90%• Etiologies of parenchymal disease include:-Acute tubular necrosis-Pigment nephropathy-Nephrotoxic agents-Acute rejection following transplantation-Prerenal and postrenal causes +++ Symptoms and Signs + • Diminished urinary output• Altered mental status• Abdominal pain• Edema• Prolonged bleeding time secondary to platelet dysfunction• Tenderness over transplant allograft• Hypertension +++ Laboratory Findings + • Elevated creatinine• Hyperkalemia• Hyperphosphatemia• Elevated blood urea nitrogen• Urine osmolarity isotonic with serum levels• Urine sodium > 40• Fractional excretion of sodium > 3%• Hyponatremia• Hypocalcemia• Metabolic acidosis• Anemia +++ Imaging Findings + • Renal US: Shows dampened waveform in arterial thrombosis or diastolic reversal of flow in venous obstruction or allograft rejection post-transplantation + • Duration since transplantation• Underlying critical illness in acute renal failure +++ Rule Out + • Renal artery or vein thrombosis immediately post-transplant• Ureter obstruction or leak post-transplant + • History and physical exam• Serum and urine creatinine• Serum and urine sodium• Serum potassium• Serum phosphate• Renal US +++ Surgery +++ Indications + • Removal of allograft if hyperacute rejection +++ Medications + • Optimization of cardiac output• Diuresis and renal replacement therapy (intermittent hemodialysis, continuous venovenous hemofiltration and dialysis if hemodynamically unstable)• Adequate nutrition• Treatment of underlying disease• Pulse corticosteroids and/or OKT3 for acute allograft rejection +++ Prognosis + • 50-90% mortality (highest if oliguric)• 90% recover renal function if survive underlying inciting illness (recovery unlikely if > 6 weeks postresolution of illness) +++ Prevention + • Avoidance of nephrotoxic agents and maintain organ perfusion in critically ill• Adequate immunosuppression and compliance post-renal transplant +++ References ++Zacharias M. et al. Interventions for protecting renal function in the perioperative period. Cochrane Database of Systematic Reviews. 2008. (4):CD003590. ++Rabindranath K. Adams J. Macleod AM. Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database of Systematic Reviews 2007. (3):CD003773. Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.